SOCS6, down-regulated in gastric cancer, inhibits cell proliferation and colony formation

Cancer Letters

Volumn 288, Issue 1, 2010, Pages 75-85

  Lai, Rai Hua ^a   Hsiao, Ya Wen ^b   Wang, Mei Jung ^b   Lin, Huan Yu ^a   Wu, Chew Wun ^c   Chi, Chin Wen ^a,c   Li, Anna Fen Yau ^c   Jou, Yuh Shan ^b   Chen, Jeou Yuan ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Gastric cancer; Growth suppression; Loss of heterozygosity; Promoter hypermethylation; SOCS6

Indexed keywords

MESSENGER RNA; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 6; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE INACTIVATION; GENE LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS;

ADENOCARCINOMA; AGED; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MIDDLE AGED; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TIME FACTORS; TRANSFECTION; TUMOR STEM CELL ASSAY;

EID: 73649123906     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.06.025     Document Type: Article

References (35)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
2. Stock M., and Otto F. Gene deregulation in gastric cancer. Gene 360 (2005) 1-19
3. Krebs D.L., and Hilton D.J. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19 (2001) 378-387
4. Kamura T., Burian D., Yan Q., Schmidt S.L., Lane W.S., Querido E., Branton P.E., Shilatifard A., Conaway R.C., and Conaway J.W. Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase. J. Biol. Chem. 276 (2001) 29748-29753
5. Zhang J.G., Metcalf D., Rakar S., Asimakis M., Greenhalgh C.J., Willson T.A., Starr R., Nicholson S.E., Carter W., Alexander W.S., Hilton D.J., and Nicola N.A. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo. Proc. Natl. Acad. Sci. USA 98 (2001) 13261-13265
6. Masuhara M., Sakamoto H., Matsumoto A., Suzuki R., Yasukawa H., Mitsui K., Wakioka T., Tanimura S., Sasaki A., Misawa H., Yokouchi M., Ohtsubo M., and Yoshimura A. Cloning and characterization of novel CIS family genes. Biochem. Biophys. Res. Commun. 239 (1997) 439-446
7. Nicholson S.E., Willson T.A., Farley A., Starr R., Zhang J.G., Baca M., Alexander W.S., Metcalf D., Hilton D.J., and Nicola N.A. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J. 18 (1999) 375-385
8. Krebs D.L., Uren R.T., Metcalf D., Rakar S., Zhang J.G., Starr R., De Souza D.P., Hanzinikolas K., Eyles J., Connolly L.M., Simpson R.J., Nicola N.A., Nicholson S.E., Baca M., Hilton D.J., and Alexander W.S. SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation. Mol. Cell Biol. 22 (2002) 4567-4578
9. Mooney R.A., Senn J., Cameron S., Inamdar N., Boivin L.M., Shang Y., and Furlanetto R.W. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J. Biol. Chem. 276 (2001) 25889-25893
10. Bayle J., Letard S., Frank R., Dubreuil P., and De Sepulveda P. Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling. J. Biol. Chem. 279 (2004) 12249-12259
11. Li L., Gronning L.M., Anderson P.O., Li S., Edvardsen K., Johnston J., Kioussis D., Shepherd P.R., and Wang P. Insulin induces SOCS-6 expression and its binding to the p85 monomer of phosphoinositide 3-kinase, resulting in improvement in glucose metabolism. J. Biol. Chem. 279 (2004) 34107-34114
12. He B., You L., Uematsu K., Zang K., Xu Z., Lee A.Y., Costello J.F., McCormick F., and Jablons D.M. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc. Natl. Acad. Sci. USA 100 (2003) 14133-14138
13. Yoshikawa H., Matsubara K., Qian G.S., Jackson P., Groopman J.D., Manning J.E., Harris C.C., and Herman J.G. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet. 28 (2001) 29-35
14. Fukushima N., Sato N., Sahin F., Su G.H., Hruban R.H., and Goggins M. Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms. Br. J. Cancer 89 (2003) 338-343
15. Fujitake S., Hibi K., Okochi O., Kodera Y., Ito K., Akiyama S., and Nakao A. Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. J. Gastroenterol. 39 (2004) 120-124
16. Oshimo Y., Kuraoka K., Nakayama H., Kitadai Y., Yoshida K., Chayama K., and Yasui W. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma. Int. J. Cancer 112 (2004) 1003-1009
17. To K.F., Chan M.W., Leung W.K., Ng E.K., Yu J., Bai A.H., Lo A.W., Chu S.H., Tong J.H., Lo K.W., Sung J.J., and Chan F.K. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line. Br. J. Cancer 91 (2004) 1335-1341
18. Galm O., Yoshikawa H., Esteller M., Osieka R., and Herman J.G. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 101 (2003) 2784-2788
19. Weber A., Hengge U.R., Bardenheuer W., Tischoff I., Sommerer F., Markwarth A., Dietz A., Wittekind C., and Tannapfel A. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene 24 (2005) 6699-6708
20. Storojeva I., Boulay J.L., Ballabeni P., Buess M., Terracciano L., Laffer U., Mild G., Herrmann R., and Rochlitz C. Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer. Oncology 68 (2005) 246-255
21. Liu C.A., Wang M.J., Chi C.W., Wu C.W., and Chen J.Y. Overexpression of rho effector rhotekin confers increased survival in gastric adenocarcinoma. J. Biomed. Sci. 11 (2004) 661-670
22. Wu C.W., Chen G.D., Fann C.S., Lee A.F., Chi C.W., Liu J.M., Weier U., and Chen J.Y. Clinical implications of chromosomal abnormalities in gastric adenocarcinomas. Genes Chromosomes Cancer 35 (2002) 219-231
23. Shen C.Y., Yu J.C., Lo Y.L., Kuo C.H., Yue C.T., Jou Y.S., Huang C.S., Lung J.C., and Wu C.W. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res. 60 (2000) 3884-3892
24. Frommer M., McDonald L.E., Millar D.S., Collis C.M., Watt F., Grigg G.W., Molloy P.L., and Paul C.L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 89 (1992) 1827-1831
25. Warnecke P.M., Stirzaker C., Song J., Grunau C., Melki J.R., and Clark S.J. Identification and resolution of artifacts in bisulfite sequencing. Methods 27 (2002) 101-107
26. Arnold N., Hagele L., Walz L., Schempp W., Pfisterer J., Bauknecht T., and Kiechle M. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer 16 (1996) 46-54
27. Barratt P.L., Seymour M.T., Stenning S.P., Georgiades I., Walker C., Birbeck K., and Quirke P. DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study. Lancet 360 (2002) 1381-1391
28. Blons H., Laccourreye O., Houllier A.M., Carnot F., Brasnu D., Beaune P., Zucman-Rossi J., and Laurent-Puig P. Delineation and candidate gene mutation screening of the 18q22 minimal region of deletion in head and neck squamous cell carcinoma. Oncogene 21 (2002) 5016-5023
29. Hermsen M.A., Joenje H., Arwert F., Welters M.J., Braakhuis B.J., Bagnay M., Westerveld A., and Slater R. Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma. Genes Chromosomes Cancer 15 (1996) 1-9
30. Huiping C., Eiriksdottir G., Sigurdsson A., Sigurgeirsdottir J.R., Barkardottir R.B., Egilsson V., and Ingvarsson S. High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content. Anticancer Res. 18 (1998) 1031-1036
31. Inoue T., Uchino S., Shiraishi N., Adachi Y., and Kitano S. Loss of heterozygosity on chromosome 18q in cohesive-type gastric cancer is associated with tumor progression and poor prognosis. Clin. Cancer Res. 4 (1998) 973-977
32. Nagy A., Buzogany I., and Kovacs G. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes. Histopathology 44 (2004) 542-546
33. Takebayashi S., Ogawa T., Jung K.Y., Muallem A., Mineta H., Fisher S.G., Grenman R., and Carey T.E. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma. Cancer Res. 60 (2000) 3397-3403
34. Yu J.C., Sun K.L., Liu B., and Fu S.B. Allelotyping for loss of heterozygosity on chromosome 18 in gastric cancer. World J. Gastroenterol. 10 (2004) 1964-1966
35. Leroith D., and Nissley P. Knock your SOCS off!. J. Clin. Invest. 115 (2005) 233-236